Sarepta Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | $26.8M | $190.3M | $80.3M |
| FY2016 | $17.7M | $336.7M | $122.4M |
| FY2017 | $431.1M | $789.2M | $599.7M |
| FY2018 | $420.6M | $1.03B | $370.8M |
| FY2019 | — | $818.2M | $835.1M |
| FY2020 | — | $761.8M | $1.50B |
| FY2021 | $563.7M | $928.0M | $2.12B |
| FY2022 | $1.54B | $385.0M | $966.8M |
| FY2023 | $1.24B | $859.3M | $428.4M |
| FY2024 | $1.14B | $1.53B | $1.10B |